Merus stock halted today as Genmab buyout closes: what happens to MRUS shares and the $97 cash payout
NEW YORK, December 30, 2025, 11:14 ET — Regular session Merus N.V. shares were halted on Tuesday after Nasdaq said the final merger step in Denmark’s Genmab’s $97-a-share cash acquisition closed before the market open, leaving the stock set for suspension on Dec. 31. Merus last traded around $90 late Monday, about 7% below its prior close, according to market data. NASDAQ Trader Why it matters now: Merus said in an SEC filing that a “back-end” merger — a squeeze-out step that follows a tender offer — and a related share cancellation took effect late Monday, leaving no common shares